Ana Maria Rivas-Grajales, MD

Assistant Professor, Psychiatry

Ana Rivas-Grajales


Dr. Ana Maria Rivas-Grajales is a Neuropsychiatrist and Assistant Professor in the Department of Psychiatry at Boston University Chobanian & Avesidian School of Medicine. She directs the Neuropsychiatry and Neuromodulation Service at Boston Medical Center. Dr. Rivas-Grajales completed residency training in psychiatry at Baylor College of Medicine where she served as chief resident of research, and a clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital.

Her clinical interests include treatment-resistant depression, the neuropsychiatry of Parkinson’s disease and epilepsy, functional neurological disorders, and early onset dementia. Her research focuses on the understanding of the mechanism of action of neuromodulation therapies for treatment-resistant depression.


  • Universidad Del Valle, MD
  • University College London (UCL), MSc


  • Published on 1/1/2022

    Molton IR, Keatley E, Jaywant A, Josephy-Hernandez S, Rivas-Grajales AM, Perez DL, Mukherjee D. Ethical issues in the treatment of functional neurological disorder. PM R. 2022 01; 14(1):112-119. PMID: 34958180.

    Read at: PubMed
  • Published on 11/5/2021

    Rivas-Grajales AM, Mathew SJ, Rodgers JJ. A Case of Intranasal Ketamine Misuse: Considerations for Clinical Practice. J Psychiatr Pract. 2021 11 05; 27(6):492-495. PMID: 34768275.

    Read at: PubMed
  • Published on 5/18/2021

    Rivas-Grajales AM, Salas R, Robinson ME, Qi K, Murrough JW, Mathew SJ. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression. Int J Neuropsychopharmacol. 2021 05 18; 24(5):383-391. PMID: 33249434.

    Read at: PubMed
  • Published on 10/28/2019

    Schanzer B, Rivas-Grajales AM, Khan A, Mathew SJ. Novel investigational therapeutics for generalized anxiety disorder (GAD). Expert Opin Investig Drugs. 2019 Nov; 28(11):1003-1012. PMID: 31607187.

    Read at: PubMed
  • Published on 6/16/2019

    Mathew SJ, Rivas-Grajales AM. "Does the opioid system block or enhance the antidepressant effects of ketamine?" Chronic Stress (Thousand Oaks). 2019 Jan-Dec/; 3. PMID: 31276079.

    Read at: PubMed
  • Published on 6/1/2016

    Kanner AM, Rivas-Grajales AM. Psychosis of epilepsy: a multifaceted neuropsychiatric disorder. CNS Spectr. 2016 Jun; 21(3):247-57. PMID: 27322691.

    Read at: PubMed

View all profiles